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Objective: Recent single-center reports demonstrate a high (up to 10%) incidence of postoperative venous thromboem-
bolism (VTE) after major vascular surgery. Moreover, vascular patients rarely receive prolonged prophylaxis despite
evidence that it reduces thromboembolic events after discharge. This study used a national, prospective, multicenter
database to deﬁne the incidence of overall and postdischarge VTE after major vascular operations and assess risk factors
associated with VTE development.
Methods: Patients with VTE who underwent elective vascular procedures (n [ 45,548) were identiﬁed from the 2007-
2009 National Surgical Quality Improvement Program (NSQIP) database. The vascular procedures included carotid
endarterectomy (CEA; n [ 20,785), open thoracoabdominal aortic aneurysm (TAAA) repair (n [ 361), thoracic
endovascular aortic repair (TEVAR; n [ 732), open abdominal aortic (OAA) surgery (n [ 6195), endovascular aneu-
rysm repair (EVAR; n [ 7361), and infrainguinal bypass graft (BPG; n [ 10,114). Univariable and multivariable
analyses were performed to ascertain risk factors associated with VTE.
Results: VTE was diagnosed in 187 patients (1.3 %) who underwent aortic surgery, with TAAA repair having the highest
rate of VTE (4.2%), followed by TEVAR (2.2%), OAA surgery (1.7%), and EVAR (0.7%). In this subgroup, pulmonary
embolisms (PE) were diagnosed in 52 (0.4%) and deep venous thrombosis (DVT) in 144 (1%). VTE rates were 1.0% and
0.2% for patients who underwent a BPG or CEA, respectively. Forty-one percent of all VTEs were diagnosed after
discharge. The median (interquartile range) number of days from surgery to PE and DVT were 10 (5-15) and 10 (4-18),
respectively. On multivariable analyses, type of surgical procedure, totally dependent functional status, disseminated
cancer, postoperative organ space infection, postoperative cerebrovascular accident, failure to wean from ventilator £48
hours, and return to the operating room were signiﬁcantly associated with development of VTE. In those experiencing
a DVT or PE, overall mortality increased from 1.5% to 6.2% and from 1.5% to 5.7% respectively (P < .05 for both).
Conclusions: Postoperative VTE is associated with the type of vascular procedure and is highest after operations in the
chest and abdomen/pelvis. About 40% of VTE events in elective vascular surgery patients were diagnosed after discharge,
and the presence of VTE was associated with a quadrupled mortality rate. Future studies should evaluate the beneﬁt of
DVT screening and postdischarge VTE prophylaxis in high-risk patients. (J Vasc Surg 2013;57:1589-96.)2Venous thromboembolism (VTE) is one of the more
preventable complications associated with surgery.1 Post-
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VTE on general and orthopedic procedures has been well
documented, there are limited reports of the role of VTE
on the morbidity and mortality associated with vascular
surgery.3 In addition, there is a paucity of data regarding
the incidence of VTE and the factors that contribute to
overall and postdischarge VTE in vascular surgery patients.
The objective of our study was to use a national, prospec-
tive, multicenter database to deﬁne the frequency of overall
and postdischarge VTE after major vascular operations and
to assess risk factors associated with VTE development after
vascular surgery.
METHODS
Data set. Data were extracted from the 2007 to 2009
American College of Surgeons (ACS) National Surgical
Quality Improvement Program (NSQIP) Participant Use
Data Files.4 These are multicenter; prospective databases
with >250 participant academic and community United
States hospitals. NSQIP processes have been previously
described in detail.4-9
Patients. Patients who underwent major elective
vascular procedures were identiﬁed from the NSQIP data
sets using the Current Procedural Terminology codes1589
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dures. The vascular procedures included in this study were
carotid endarterectomy (CEA), open thoracoabdominal
aortic aneurysm (TAAA) repair, thoracic endovascular
aortic repair (TEVAR), open abdominal aortic (OAA)
surgery, endovascular aneurysm repair (EVAR) and infrain-
guinal bypass graft (BPG; Table I).
Preoperative data analyzed included demographic, life-
style, comorbidity, and other variables. The full deﬁnition
of all variables has been previously described.4
Outcomes. The primary outcome of interest was post-
operative VTE, which occurred if deep venous thrombosis
(DVT), pulmonary embolism, (PE), or both, developed
postoperatively. The incidence and risk factors for overall
and postdischarge VTE events were analyzed separately.
The NSQIP database captures VTE incidence for 30 days
after surgery.
Deﬁnitions. Postoperative DVT is deﬁned in NSQIP
as “the identiﬁcation of a new blood clot or thrombus
within the venous system, which may be coupled with
inﬂammation, within 30 days of the operation. This diag-
nosis is conﬁrmed by a duplex, venogram or computed
tomography (CT) scan. The patient must be treated with
anticoagulation therapy and/or placement of a vena cava
ﬁlter or clipping of the vena cava.”4 Similarly, NSQIP
deﬁnes postoperative PE as the “lodging of a blood clot in
a pulmonary artery with subsequent obstruction of blood
supply to the lung parenchyma. In addition, the patient has
a V-Q scan interpreted as high probability of pulmonary
embolism or a positive CT spiral exam, pulmonary arte-
riogram, or CT angiogram.”4
Statistical analysis. Univariable analyses were per-
formed using the Pearson c2 test or Fisher exact test
for categoric variables, and two-sided Student t- or F-test
for continuous variables. P< .05 was considered signiﬁcant.
Multivariable logistic regression analyses were used to
create two independent risk assessment models for overall
and postdischarge VTE. Preoperative and demographic
variables that had a P < .5 on univariable analyses were
considered for inclusion in the ﬁnal risk adjustment models.
P < .05 was the threshold for a variable to remain in the
models.
Model quality was evaluated using Hosmer-Lemeshow
goodness-of-ﬁt (GOF) test for calibration and the C statistic
for discrimination. Calibration examines how well the
percentage of observed VTE events matches the percentage
of predicted VTE events over deciles of predicted risk. The
C statistic refers to the ability of the risk estimate to discrim-
inate cases (VTE) from noncases (no VTE). If the C
statistic ¼ 1.0, then discrimination is perfect, whereas if
the C statistic ¼ 0.50, then discrimination is no better
than chance.10 Median data are presented with the inter-
quartile range (IQR). Statistical analyses were performed
using SPSS 17.0 software (SPSS Inc, Chicago, Ill).
RESULTS
Surgery characteristics. The following elective vas-
cular procedures were done in 45,548 patients: CEA in20,785, TAAA repair in 361, TEVAR in 732, OAA
surgery in 6195, EVAR in 7361, and BPG in 10,114.
TAAA repair had the highest rate of VTE (4.2%), followed
by TEVAR (2.2%), OAA surgery (1.7%), BPG (1.0%),
EVAR (0.7%), and CEA (0.2%; P < .0001). Overall,
VTE was diagnosed in 332 patients (0.7%), with PE diag-
nosed in 0.2% and DVT in 0.6%. Because CEA consti-
tuted 45.6% of all procedures and had a VTE rate of
only 0.2%, we performed a subgroup analysis of the
24,753 patients who underwent aortic procedures and
BPG. VTE was diagnosed in 286 patients (1.2%) in this
subgroup, PE was diagnosed in 71 (10.3%), and DVT in
227 (0.9%).
Diagnosis of 41% of VTEs among the overall patient
cohort was made after discharge. In the subgroup under-
going aortic procedures and BPG (excluding CEA), 37.4%
of VTEs were detected after discharge. Among these
patients, TEVAR had highest rate of postdischarge VTE
(1%), followed by TAAA repair (0.6%), BPG (0.5%), OAA
surgery (0.4%), EVAR (0.3%), and CEA (0.1%; P <
.0001). The median (IQR) number of days from surgery
to overall PE and DVT were 10 (5-15) and 10 (4-18)
days, respectively. Mortality was 6% in those experiencing
a VTE compared with 1.5% among patients without VTE
(P < .0001).
Demographics and preoperative comorbidities.
Patients were a median age of 71 years (IQR, 63-78 years),
35% were women, and the median body mass index was
28.14 kg/m2 (IQR, 24.9-32 kg/m2). Certain cardiovas-
cular, renal, neurologic, infectious, and respiratory comor-
bidities were more common in patients who developed
a VTE (P < .05; Table II). Patients who developed a VTE
were also older, had a higher incidence of disseminated
cancer, and were more functionally dependent (P< .0001).
Variations in surgeries, American Society of Anesthesiolo-
gists Physical Status Classiﬁcation, and wound class were
observed (Table II). Patients who were diagnosed with
a postoperative VTE had longer operative times (P< .0001;
Table II).
Univariable analyses of postoperative outcomes.
Patients who developed a postoperative VTE had signiﬁ-
cantly higher rates of postoperative cardiovascular, graft,
renal, neurologic, infectious, wound, and respiratory
complications (P < .0001; Table III). More than one-
fourth of patients who returned to the operating room
developed a VTE. Figs 1 and 2 depict the incidence of
overall and postdischarge VTE, respectively, in patients
who developed postoperative complications. The median
(IQR) hospital length of stay (LOS) for the entire patient
cohort was 2 (1-5) days and was signiﬁcantly longer at 9
(4-17) days in patients who experienced a VTE. In the
subgroup undergoing aortic surgery and BPG, the median
(IQR) hospital LOS was 4 days (2-7 days) and increased to
9.5 days (5-19 days) in those who experienced a VTE. The
incidence of VTE was signiﬁcantly higher in patients
who had a postoperative complication (2.4%) than in
patients who had no postoperative complications (0.4%,
P < .0001). Similarly, the incidence of postdischarge VTE
Table I. Current Procedural Terminology (CPT) codesa
CPT code Description
33877 Repair of thoracoabdominal aortic aneurysm with graft, with or without cardiopulmonary bypass
33880 Endovascular repair of descending thoracic aorta (eg, aneurysm, pseudoaneurysm, dissection, penetrating ulcer, intramural
hematoma, or traumatic disruption); involving coverage of left subclavian artery origin, initial endoprosthesis plus
descending thoracic aortic extension(s), if required, to level of celiac artery origin
33881 Endovascular repair of descending thoracic aorta (eg, aneurysm, pseudoaneurysm, dissection, penetrating ulcer, intramural
hematoma, or traumatic disruption); not involving coverage of left subclavian artery origin, initial endoprosthesis plus
descending thoracic aortic extension(s), if required, to level of celiac artery origin
33883 Placement of proximal extension prosthesis for endovascular repair of descending thoracic aorta (eg, aneurysm,
pseudoaneurysm, dissection, penetrating ulcer, intramural hematoma, or traumatic disruption)
33884 Placement of proximal extension prosthesis for endovascular repair of descending thoracic aorta (eg, aneurysm,
pseudoaneurysm, dissection, penetrating ulcer, intramural hematoma, or traumatic disruption); each additional proximal
extension (List separately in addition to code for primary procedure)
33886 Placement of distal extension prosthesis(s) delayed after endovascular repair of descending thoracic aorta
34800 Endovascular repair of infrarenal abdominal aortic aneurysm or dissection; using aorto-aortic tube prosthesis
34802 Endovascular repair of infrarenal abdominal aortic aneurysm or dissection; using modular bifurcated prosthesis (one
docking limb)
34803 Endovascular repair of infrarenal abdominal aortic aneurysm or dissection; using modular bifurcated prosthesis (two
docking limbs)
34804 Endovascular repair of infrarenal abdominal aortic aneurysm or dissection; using unibody bifurcated prosthesis
34805 Endovascular repair of infrarenal abdominal aortic aneurysm or dissection; using aorto-uniiliac or aorto-unifemoral prosthesis
35081 Direct repair of aneurysm, pseudoaneurysm, or excision (partial or total) and graft insertion, with or without patch graft; for
aneurysm, pseudoaneurysm, and associated occlusive disease, abdominal aorta
35091 Direct repair of aneurysm, pseudoaneurysm, or excision (partial or total) and graft insertion, with or without patch graft; for
aneurysm, pseudoaneurysm, and associated occlusive disease, abdominal aorta involving visceral vessels (mesenteric, celiac,
renal)
35102 Direct repair of aneurysm, pseudoaneurysm, or excision (partial or total) and graft insertion, with or without patch graft; for
aneurysm, pseudoaneurysm, and associated occlusive disease, abdominal aorta involving iliac vessels (common,
hypogastric, external)
35301 Thromboendarterectomy, including patch graft if performed: carotid, vertebral, subclavian, by neck incision
35341 Thromboendarterectomy mesenteric, celiac or renal
35531 Bypass graft with vein, aortoceliac or aortomesenteric
35535 Bypass graft with vein, hepatorenal
35536 Bypass graft with vein, splenorenal
35537 Bypass graft with vein, aortoiliac
35538 Bypass graft with vein, aortobi-iliac
35539 Bypass graft with vein, aortofemoral
35540 Bypass graft with vein, aortobifemoral
35548 Bypass graft with vein, aortoiliofemoral, unilateral
35549 Bypass graft with vein, aortoiliofemoral, bilateral
35556 Bypass graft with vein, femoral-popliteal
35560 Bypass graft with vein, aortorenal
35566 Bypass graft with vein, femoral-anterior tibial, posterior tibial, peroneal artery or other distal vessels
35570 Bypass graft with vein, tibial- tibial, peroneal-tibial or tibial/ peroneal trunk-tibial
35571 Bypass graft with vein, popliteal-tibial, -peroneal artery or other distal vessels
35583 In-situ vein bypass, femoral-popliteal
35585 In-situ vein bypass, femoral-anterior tibial, posterior tibial, or peroneal artery
35587 In-situ vein bypass, popliteal-tibial, peroneal
35631 Bypass graft, with other than vein, aortoceliac, aortomesenteric, aortorenal
35632 Bypass graft, with other than vein, ilio-celiac
35633 Bypass graft, with other than vein, ilio-mesenteric
35634 Bypass graft, with other than vein, iliorenal
35636 Bypass graft, with other than vein, splenorenal
35637 Bypass graft, with other than vein, aortoiliac
35638 Bypass graft, with other than vein, aortobi-iliac
34646 Bypass graft, with other than vein, aortobifemoral
35647 Bypass graft, with other than vein, aortofemoral
35656 Bypass graft, with other than vein, femoral-popliteal
35666 Bypass graft, with other than vein, femoral-anterior tibial, posterior tibial, or peroneal artery
35671 Bypass graft, with other than vein, popliteal-tibial or -peroneal artery
aAmerican Medical Association, Chicago, Ill.
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tion (0.7%) than in patients who had no postoperative
complications (0.2%; P < .0001).Multivariable regression analysis for overall post-
operative VTE. On multivariable logistic regression, after
controlling for >50 comorbidities and type of surgery, risk
Table II. Preoperative features
Parametera
No VTE
(n ¼ 45,216)
VTE
(n ¼ 332) VTE, % Pb
Procedure type
CEA 20,739 46 0.2 <.0001
TAAA repair 346 15 4.2
TEVAR 716 16 2.2
OAA surgery 6092 103 1.7
Infrainguinal
BPG
10,015 99 1
EVAR 7308 53 0.7
Transition
At home 43,708 312 0.7 .02
Acute care
facility
801 14 1.7
Chronic care
facility
580 4 0.7
VA acute care
facility
25 0 0
VA chronic care
facility
3 0 0
Other 99 2 0.2
Sex
Female 15,969 114 0.7 .9
Male 29,246 218 0.7
Race
American Indian 140 0 0 .049
Asian 542 4 0.7
African
American
3154 36 1.1
Hispanic 1330 13 1
Unknown 2693 14 0.5
Caucasian 37,357 265 0.7
Anesthesia
Regional 5970 23 0.4 .001
General 39,246 309 0.8
Age, years 71 (63-78) 70 (61-78) NA <.0001
Body mass index,
kg/m2
28.14
(24.9-31.9)
27.7
(24.7-32.9)
NA .8
Diabetes
No 32,974 246 0.7 .4
On insulin 5696 34 0.6
On oral
hypoglycemics
6546 52 0.8
Smoking 15,559 118 0.8 .7
Alcohol 2252 20 0.9 .4
Dyspnea
None 36,113 238 0.7 .01
On moderate
exertion
8477 88 1
At rest 626 6 0.9
Do not resuscitate 250 2 0.8 .6
Functional status
Totally
dependent
256 5 1.9 <.0001
Partially
dependent
3027 42 1.4
Independent 41,933 285 0.7
COPD 6066 61 1 .008
Pneumonia 70 0 0 .6
Myocardial
infarction
642 6 0.9 .3
Congestive heart
failure
526 10 1.9 .006
Previous PCI 8509 61 0.7 .8
Table II. Continued.
Parametera
No VTE
(n ¼ 45,216)
VTE
(n ¼ 332) VTE, % Pb
Previous cardiac
surgery
10,451 70 0.7 .4
Angina 927 13 1.4 .01
Hypertension 37,703 284 0.7 .3
History of PVD 8806 83 0.9 .002
Rest pain 5701 61 1.1 .19
Dialysis 937 12 1.3 .05
Impaired
sensorium
187 3 1.6 .2
Hemiplegia 1612 12 0.7 .96
Transient ischemic
attack
7369 40 0.5 .04
CVA 4454 34 0.8 .8
CVA without
neurologic
deﬁcit
3288 19 0.6 .3
Central nervous
system tumor
24 0 0 .8
Paraplegia 178 3 1.7 .1
Disseminated
cancer
21 3 12.5 <.0001
Open wound 4328 43 1 .04
Chronic
corticosteroid
use
1287 16 1.2 .03
Weight loss 566 12 2.1 <.0001
Bleeding disorder 7836 60 0.8 .7
Preoperative SIRS 617 13 2.1 .001
Previous surgery
#30 days
1087 20 1.8 <.0001
ASA class
1 1282 9 0.7 <.0001
2 13,936 92 0.7
3 25,020 165 0.7
4 4927 66 1.3
5 22 0 0
Wound class
Clean 43,689 311 0.7 .03
Clean
contaminated
579 9 1.5
Contaminated 600 8 1.3
Dirty 348 4 1.1
PRBC transfused 0 (0) 0 (0-2) NA <.0001
Operative time,
minutes
141
(101-205)
201
(137.25-296)
NA <.0001
Length of stay,
days
2 (1-5) 9 (4-17) NA <.0001
ASA, American Society of Anesthesiologists; BPG, bypass graft; CEA,
carotid endarterectomy; CHF, congestive heart failure; COPD, chronic
obstructive pulmonary disease; CVA, cerebrovascular accident; EVAR,
endovascular aneurysm repair; IQR, interquartile range; NA, not applicable;
OAA, open abdominal aortic; PCI, percutaneous coronary intervention;
PRBC, intraoperative packed red blood cells; PVD, peripheral vascular
disease; SIRS, systemic inﬂammatory response syndrome; TAAA, thor-
acoabdominal aortic aneurysm; TEVAR, thoracic endovascular aortic repair;
TIA, transient ischemic attack; VA, Veterans Affairs.
aCategoric data are expressed as number; continuous data as median (IQR).
bP reﬂects univariable analysis: Pearson c2 test and F test; P < .05 is
signiﬁcant.
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surgery, totally dependent functional status, disseminated
cancer, postoperative cerebrovascular accident, organ space
Table III. Postoperative complications
Postoperative complication
No VTE,
No.
VTE,
No. Pa
Urinary tract infection 698 28 <.0001
Superﬁcial infection 1172 13 .13
Deep wound infection 392 4 .54
Organ space infection 95 8 <.0001
Dehiscence 286 7 .006
Pneumonia 876 43 <.0001
Reintubation 971 52 <.0001
Failure to wean off ventilator 1028 73 <.0001
Renal insufﬁciency 285 13 <.0001
Dialysis 379 19 <.0001
Stroke 457 19 <.0001
Coma 49 4 .001
Neurologic deﬁcit 88 3 .03
Cardiac arrest 286 17 <.0001
Myocardial infarction 428 12 <.0001
Bleeding 365 14 <.0001
Graft failure 672 15 <.0001
Sepsis 715 26 <.0001
Septic shock 505 37 <.0001
Return to operating room 3682 94 <.0001
VTE, Venous thromboembolism.
aP reﬂects univariable analysis: Pearson c2 and F test, comparing the post
operative outcomes in patients without and with a VTE. P < .05 is
signiﬁcant.
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operating room (Table IV). The model demonstrated
excellent discrimination (C statistic ¼ 0.84) and calibration
(Hosmer-Lemeshow GOF test c2 ¼ 7.87; P ¼ .45).
Multivariable regression analysis for postdischarge
VTE. Risk factors for postdischarge VTE diagnosis on
multivariable logistic regression were procedure type,
totally dependent functional status, disseminated cancer,
and postoperative myocardial infarction (Table V). This
multivariate logistic model also had excellent discrimina-
tion (C statistic ¼ 0.85) and calibration (Hosmer-Leme-
show GOF test c2 ¼ 5.18; P ¼ .74).DISCUSSION
VTE is considered by the Agency for Healthcare
Research and Quality (AHRQ) as a patient safety indi-
cator.11 PE is the most common preventable cause of
hospital death and thus is an integral part of the effort to
improve patient safety in hospitals.12 Vascular surgery
patients have several characteristics that put them at
a high risk of developing VTE, such as older age, limited
mobility, limb ischemia, long duration of surgery, and
intraoperative local trauma, including possibility of venous
injury, atherosclerosis itself, and a higher rate of comorbid-
ities.3,13 In a study by Huerta et al,14 the odds ratio of
developing VTE after vascular surgery was 9.34 (95%
conﬁdence interval, 5.32-16.38) compared with no
surgery, which was third only to musculoskeletal surgery
and neurosurgery. However, the study did not describe
the types of vascular procedures performed. Rogerset al15 studied different vascular procedures and assigned
a high VTE risk score for several of these operations.
Despite this, the American College of Chest Physicians
recommendations for thromboprophylaxis after vascular
surgery are mainly based on effectiveness of chemical
prophylaxis in general surgery patients.16 Eight random-
ized trials for VTE prophylaxis after vascular surgery were
evaluated. The evidence for prophylaxis in high-risk
vascular surgery patients was grade 1C, whereas that for
low-risk vascular surgery patients was grade 2B, with all
trials having a small number of patients.3,13,16
Although data on in-hospital VTE prophylaxis in
patients undergoing vascular surgery are limited, there are
none regarding VTE events after discharge. Extended-
duration thromboprophylaxis (28-45 days) is known to
reduce the risk of VTE in high-risk patients and is cost-
effective.17 The scarcity of quality data on postoperative
and postdischarge VTE in patients undergoing vascular
surgery highlights the importance of the ﬁndings from
this national data set.
Our study found the type of vascular procedure was
itself an independent risk factor associated with overall
and postdischarge VTE. The VTE incidence after abdom-
inal aortic surgery seems to be similar to the reported inci-
dence in literature of 1% to 24%.3,18-21 Our analysis almost
certainly underestimates the incidence of VTE events
because patients in the NSQIP database were not routinely
screened with venous duplex ultrasound imaging; however,
this is more reﬂective of real-world practice of performing
a venous duplex assessment only when clinically relevant.
To our knowledge, this is the only study reported thus
far to look speciﬁcally at the incidence of VTE after CEA
and thoracic and TAAA procedures. TAAA repair and
TEVAR had the highest incidence of overall and postdi-
scharge VTE events (4.2% and 2.2%, respectively, for overall
VTE and 0.6% and 1%, respectively, for postdischarge VTE)
among the vascular procedures studied, whereas CEA had
the lowest incidence (0.2%) of VTE. This may be because
spinal drains are placed for protection from paraplegia in
most patients undergoing TAAA repairs and in many
undergoing TEVARs, and as a consequence, they do not
receive VTE prophylaxis for the ﬁrst 48 to 72 hours.
Conversely, patients undergoing CEA are able to
ambulate early after their operation, in contrast to other
vascular procedures, highlighting the importance of early
ambulation for reduction of VTE risk. Other factors that
contribute to the low incidence of VTE after CEA could
be the shorter duration of surgery, aggressive antiplatelet
strategies, and not entering a major body cavity. Abdom-
inal surgery leads to a postoperative hypercoagulable state
for at least 14 days and possibly as long as a month.22
Patients undergoing major abdominal or pelvic general
surgical procedures are considered to be at a higher risk
for development of postoperative VTE, which was similarly
found among vascular patients in our study.
Disseminated cancer was a risk factor associated with
VTE in vascular patients. Patients with neoplastic diseases
have a threefold to sixfold increased risk of developing
Fig 1. Incidence of venous thromboembolism (VTE) in patients with postoperative complications. OR, Operating
room.
Fig 2. Incidence of postdischarge venous thromboembolism (VTE) in patients with postoperative complications. OR,
Operating room.
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possibly acting throughmechanisms such as hypoﬁbrinolysis,
the release of thromboplastic substances by the tumor, and
activation of the coagulation pathway.24 Several studies
have shown that patients who have oncologic surgery beneﬁt
by extending thromboprophylaxis for 4 weeks aftersurgery,25,26 and this may be applicable to patients with
cancer undergoing certain vascular procedures. Totally
dependent functional status was also a signiﬁcant risk factor
for overall and postdischarge VTE occurrence in our study,
in line with literature demonstrating that immobilization
is associated with a 25-fold higher risk of DVT.27
Table IV. Multivariable analyses of venous
thromboembolism (VTE)
Parameter OR (95% CI) VTE, %
Procedurea
TAAA repair 3.71 (1.12-12.26) 4.2
TEVAR 4.96 (1.94-12.69) 2.2
OAA surgery 4.23 (2.23-7.99) 1.7
Infrainguinal BPG 3.33 (1.67-6.63) 1
EVAR 2.82 (1.46-5.47) 0.7
CEA Not applicable 0.2
Totally dependent functional
status
1.96 (1.18-3.28) 1.9
Disseminated cancer 16.39 (3.10-83.33) 12.5
Postoperative
Cerebrovascular accident 2.58 (1.14-5.81) 4
Organ space infection 3.25 (1.10-9.61) 7.8
Failure to wean 4.18 (2.18-8.06) 6.6
Return to operating room 2.09 (1.34-3.27) 2.5
BPG, Bypass graft; CEA, carotid endarterectomy; CI, conﬁdence interval;
EVAR, endovascular aneurysm repair; NA, not applicable; OAA, open
abdominal aortic; OR, odds ratio; TAAA, thoracoabdominal aortic aneu-
rysm; TEVAR, thoracic endovascular aortic repair.
aReference indicator: CEA.
Table V. Multivariable analyses of postdischarge venous
thromboembolism (VTE)
Parameter OR (95% CI)
Postdischarge
VTE, %
Procedurea
TAAA repair 3.95 (0.73-21.31) 0.6
TEVAR 2.31 (0.77-6.96) 1
OAA surgery 4.55 (1.61-12.84) 0.4
Infrainguinal BPG 2.6 (0.96-7.02) 0.5
CEA Not applicable 0.1
Totally dependent
functional status
5.14 (2.41-10.97) 0.8
Disseminated cancer 1.35 (1.26-142.86) 4.2
Postoperative myocardial
infarction
5.55 (1.52-20.41) 1.4
BPG, Bypass graft; CEA, carotid endarterectomy; CI, conﬁdence interval;
OAA, open abdominal aortic; OR, odds ratio; TAAA, thoracoabdominal
aortic aneurysm; TEVAR, thoracic endovascular aortic repair.
aReference indicator: CEA.
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nation of mechanical and pharmacologic prophylaxis at an
early stage of illness.
Most of the postoperative complications studied were
associated with a high incidence of VTE. Postoperative
events, such as development of a cerebrovascular accident,
organ space infection, failure to wean from ventilator, and
return to the operating room were risk factors for detection
of VTE. These complications may be associated with pro-
longed immobilization, which is a known risk factor for
DVT. A study by Scarborough et al28 of open aortic
surgeries similarly found postoperative adverse events
were associated with development of VTE. Their study
evaluated only aortic procedures, and hence, even though
it is similar to our study, has limited applicability. Postoper-
ative complications, especially infectious complications
such as organ space infection, involve systemic inﬂamma-
tion that has been postulated to promote venous throm-
bosis and inhibit ﬁbrinolysis increasing VTE risk.29
Forty-one percent of VTE events were detected after
discharge. The median LOS after arterial surgery in our
study was 2 days (IQR, 1-5 days), which was mainly due
to CEA being the most common procedure performed.
On analysis of the aortic surgery and BPG group alone,
the median LOS increased to 4 days (IQR, 2-7 days).
The median time to detection of both DVT and PE
however, was 10 days (IQR, 4-18 days). This emphasizes
the importance of being vigilant and actively investigating
signs and symptoms of VTE during postoperative visits.
Similar to overall VTE, patients with several postoperative
complications had high incidence of postdischarge VTE.
Postoperative myocardial infarction was an independent
risk factor for postdischarge VTE detection on multivari-
able analysis. The strong systemic inﬂammation that occurs
with myocardial infarction is thought to override thebeneﬁt provided by the anticoagulation these patients
receive, thus contributing to VTE development.29 The
standard in-hospital thromboprophylaxis may not provide
adequate protection against such events.17 Hence,
extended duration thromboprophylaxis (28-45 days) or
routine DVT screening for patients with previously demon-
strated risk factors undergoing thoracic or OAA vascular
procedures may be warranted.
This study, based on the NSQIP database, has many
strengths not seen in other studies, including a large sample
size that enables more precise conﬁdence intervals in the
assessment of risk factors. The current study also presents
one of the most representative estimates of the risks associ-
ated with postoperative VTE after different vascular proce-
dures in a broad nationwide population setting. Our study
is based on multi-institutional data that have been indepen-
dently validated and audited and analyzes multiple preoper-
ative variables. Further, the diagnosis of VTE is based on
objective criteria rather than subjective symptomatology.
This study has some limitations. First, only the speciﬁc
outcome of VTE at 30 days after surgery is evaluated.
Effects on quality of life and long-term sequelae of VTE,
such as post-thrombotic syndrome, cannot be evaluated
with this database. The database has no information on
patient symptoms, use of perioperative VTE prophylaxis,
intraoperative anticoagulation, or perioperative use of anti-
platelet agents. Finally, due to lack of routine screening for
VTE, the incidence of VTE may be underestimated in the
NSQIP database, which only makes the need for further
study of this problem more pressing. This is an important
consideration because recent data indicate that two-thirds
of the patients found to have DVT during screening after
vascular operations have no signs or symptoms of the
problem.30
CONCLUSIONS
VTE was diagnosed in 0.7% of patients undergoing
elective arterial operations and was detected in 1.2% of
JOURNAL OF VASCULAR SURGERY
1596 Ramanan et al June 2013the patients undergoing aortic surgery or BPG. Develop-
ment of VTE was associated with a signiﬁcantly higher
mortality rate. Thoracic and OAA vascular procedures,
totally dependent functional status, disseminated cancer,
and postoperative adverse events were associated with
increased overall and postdischarge VTE events. Our anal-
ysis may be helpful for patient counseling and for studying
appropriate prophylactic anticoagulation strategies in high-
risk patient groups. Given that 41% of VTE events were
detected after discharge, high-risk patients may beneﬁt
from postdischarge chemical prophylaxis.
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